ArticleInternational journal of hematology2021

Beneficial tyrosine kinase inhibitor therapy in a patient with relapsed BCR-ABL1-like acute lymphoblastic leukemia with CCDC88C-PDGFRB fusion.

Shuki Oya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.